Perspective of antiviral therapeutics for hepatitis C after liver transplantation

doi:10.5497/wjp.v3.i4.193

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6976)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

281

WORD

276

HTML

1957

Figures (1-2)

111

Tables (1-1)

128

Sum=2753

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

663

Download

1291

Sum=1954

Publishing Process of This Article

Item

Count

Browse

1130

Download

1139

Sum=2269

Dec 9, 2014 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Therapeutics Advances

World J Pharmacol. Dec 9, 2014; 3(4): 193-198
Published online Dec 9, 2014. doi: 10.5497/wjp.v3.i4.193

Open in New Tab Full Size Figure Download Figure

Figure 1 Post-transplant course of a liver recipient with hepatitis C recurrence.

Open in New Tab Full Size Figure Download Figure

Figure 2 Magnetic resonance imaging screening for liver graft vascular or biliary complications.

Citation: Ho CM, Hu RH, Lee PH. Perspective of antiviral therapeutics for hepatitis C after liver transplantation. World J Pharmacol 2014; 3(4): 193-198
URL: https://www.wjgnet.com/2220-3192/full/v3/i4/193.htm
DOI: https://dx.doi.org/10.5497/wjp.v3.i4.193